Richard Boardman
Optometrist · Logan, UTNPI 1346764511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 39.2% of the total. Reporting peaked in 2022 at $145 and has fallen 71.1% since, to $42 in 2024. That places this record below the midpoint for optometrist clinicians in UT, where the typical reported total is $753.
Across 19 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$130
- Bausch & Lomb, A Division Of Bausch Health US, LLC$40
- Rxsight Inc$39
- Alcon$37
- Sight Sciences, Inc.$34
- Kala Pharmaceuticals, Inc.$21
- plus $31 from 2 others
What the payments were for
- Speaking & faculty fees$268%
- Food & beverage$30792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 7 | $130 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $40 |
| Rxsight Inc | 2 | $39 |
| Alcon | 3 | $37 |
| Sight Sciences, Inc. | 2 | $34 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
| Johnson & Johnson Vision Care, Inc. | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $12 |
How this compares
$333 in reported general payments places this provider in the 30th percentile of 423 optometrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 69 | $2,667 |
| Latanoprost | 100 | $1,013 |
| Brimonidine Tartrate | 12 | $367 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 22 | $304 |
| Timolol Maleate | 23 | $224 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Logan
- Jeffrey CromwellLogan$4K
- Stephen ReinhartHill Afb$134K
- Robert WooldridgeMurray$69K
- Ian WhippleFarr West$60K
- Rhett VeaterWest Jordan$52K
- Jonathan KingSouth Ogden$42K
- Collin GrayLehi$30K
- Sean CushmanSalt Lake City$25K
- Brian RowleyPayson$15K
- Michael HillMurray$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.